Clinical Trial

Effect of Rutin on Inflammation Pathways in Ulcerative Colitis Patients

Completed Phase 2
View on ClinicalTrials.gov →
Summary
This study evaluates the therapeutic role of Rutin (a plant-derived flavonoid) in reducing the severity of Ulcerative Colitis (UC). The study investigates whether Rutin can decrease intestinal inflammation and improve clinical symptoms by inhibiting the NLRP3 inflammasome signaling pathway, which is activated by oxidative stress in the colon.
Trial Details
NCT Number NCT07370220
Lead Sponsor Benha University
Conditions Ulcerative Colitis
Enrollment 60 participants
Start Date 2025-02-22
Primary Completion 2025-05-25 (estimated)
Study Completion 2025-11-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-27